Biology & Diagnosis of PGM1-CDG

To understand PGM1-CDG, it helps to look at the biology of how your body uses sugar. While most people think of sugar only as “fuel,” your body actually uses it for two distinct, vital purposes. PGM1-CDG is a dual disruption because the missing enzyme—phosphoglucomutase 1—is the bridge between these two worlds ^[1][2].

The Biological “Bridge”

Think of your body as a construction site.

1. The Fuel Tank (Glycogen Metabolism): Your body stores sugar (glucose) in long chains called glycogen. When you need energy, the PGM1 enzyme helps unlock that tank. In PGM1-CDG, the energy is “trapped,” leading to muscle pain and low blood sugar ^[2][3].
2. The Finishing Shop (Glycosylation): Your body also uses sugar to “decorate” its proteins. This process, called glycosylation, adds complex sugar chains to proteins so they can function. Without PGM1, the body runs low on the “building blocks” (like UDP-galactose) needed for these decorations ^[3][4].

Because PGM1 sits right in the middle of these two processes, its absence causes a “double hit” to your health.

The Danger of Misdiagnosis: Why Lactose Matters

In infants, PGM1-CDG is frequently mistaken for lactose intolerance because it can cause diarrhea, poor growth, and liver stress ^[5].

Standard treatment for lactose intolerance is a lactose-free diet. However, lactose is the body’s primary dietary source of galactose—the very sugar that PGM1-CDG patients are desperately lacking for their “finishing shop.” Research has shown that putting a PGM1-CDG infant on a lactose-free diet without replacing the galactose can lead to rapid deterioration, including severe liver failure and worsening hypoglycemia ^[5]. Conversely, supplementing with galactose often helps “refill” the missing sugar pools and improves symptoms ^[4][6].

Important: Lactose or galactose should never be removed without a metabolic team’s plan. If a lactose-free formula is clinically necessary (for example, due to a true cow’s milk protein allergy), a metabolic dietitian must provide a structured D-galactose replacement plan. PGM1-CDG is distinct from classic galactosemia, where galactose restriction is required.

The Diagnostic Journey

Doctors generally use several tests to evaluate and confirm a diagnosis of PGM1-CDG. These tests are not always done in a fixed sequence and may be performed in parallel.

1. The Transferrin Screen

A common biochemical test is transferrin glycan analysis. This blood test looks at a specific protein (transferrin) to see if its sugar “decorations” are correct.

• What to look for: In PGM1-CDG, the lab report often shows a “mixed type I/type II pattern,” meaning the protein is missing entire sugar chains (Type I) and also has “broken” or shortened sugar chains (Type II) ^[7][8]. However, a nonclassic or normal result does not automatically exclude the diagnosis.
• Modern Methods: Scientists can perform this test using dried blood spots sent to validated specialist laboratories, which can be stored for months ^[9][5].

2. Genetic Testing

Molecular testing aims to find biallelic mutations in the PGM1 gene—meaning one genetic change was inherited from each parent ^[10].

• Important Note: If standard sequencing only finds one mutation but the clinical picture looks like PGM1-CDG, doctors should look for structural variants. These are larger “rearrangements” of the DNA (like an inversion) that standard tests sometimes miss ^[11].

3. Enzyme Activity

If genetic testing is unresolved, scientists can measure the actual activity of the PGM1 enzyme in the blood, skin cells, or muscle tissue ^[12][9]. Invasive muscle tissue biopsies are typically reserved for selected unresolved cases.

Reading Your Lab Reports

When you look at your medical records, you may see terms like “hyposialylation” or “reduced galactosylation.” These are scientific ways of saying that the sugar “coatings” on your proteins are incomplete because the body didn’t have enough galactose-based building blocks to finish the job ^[13][6].